PROJECTS
>>Ramp up of Product Development Efficiencies
>>Transformation through In-Licensing & Site Transfers
>>Out-License of New Molecular Entity by Biotech Footprint Late
>>Strengthening of Overseas Footprint
>>Divestment of Late Life Cycle Products
>>Commercializing a Reformulated Product
>>Business Development for Development Stage Enabling Technology
>>Restructuring Clinical Operations
>>Optimal Drug Development Path and Licensing Process
>>Post-Merger integration of Research and Development operations
Clinical Development
A North American company was developing a portfolio of product candidates for the treatment of cancer by combining immunotherapeutic antibodies with chemotherapy, radio-immunotherapy or immune adjuvants. Their technology platform included a series of monoclonal antibodies that target several different cancer markers and have potential for development in multiple indications. The company wanted to do a clinical trial in advanced pulmonary cancer patients and were evaluating various options. Garphi was able to locate a CRO which offered to recruit patients in Europe and India. The client benefited as we were able to offer time savings of 4-6 months and cost savings of 22% from the best quotes that they had. Thanks to the project management teams of the client, Garphi and the CRO the trial is progressing very smoothly, the complexities not with standing – Recruitment of 48 lung cancer patients, 5 sites, 18 monitoring visits, treatment period of 6 months and follow up period of 30 months.
